The university does not have a campus-wide policy on the use of artificial intelligence, electing to leave the discretion up ...
5d
With the flip of a switch, scientists harness light to program how particles interact and assemble
NYU scientists are using light to precisely control how tiny particles organize themselves into crystals. Their research, published in Chem, provides a simple and reversible method for forming ...
PORT ARTHUR, Texas — The city of Port Arthur plans to launch a new 3-1-1 non-emergency service next month aimed at improving communication between residents and city officials. Starting March 1, ...
The Storage Closet in Schedule 1 was added with the v0.4.3 update and is one of the most useful additions in the game. If you are running out of space or just want a cleaner and better organized ...
Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...
Rocket Lab Corporation (RKLB) announced that its Neutron rocket's Stage 1 tank ruptured during a hydrostatic pressure trial. The company noted that testing failures are not uncommon during ...
Rocket Lab suffered a structural failure of the Neutron rocket’s Stage 1 tank during testing, setting back efforts to get to the inaugural flight for the fully reusable launcher. The mishap occurred ...
Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...
Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...
SAN FRANCISCO, Jan 12 (Reuters) - Nvidia (NVDA.O), opens new tab and U.S. pharma giant Eli Lilly (LLY.N), opens new tab will spend $1 billion building a new joint research lab in the San Francisco Bay ...
The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...
People who take GLP-1 drugs are spending less money on food, according to a new study Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her work has previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results